<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Borderline personality disorder: Epidemiology, pathogenesis, clinical features, course, assessment, and diagnosis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Borderline personality disorder: Epidemiology, pathogenesis, clinical features, course, assessment, and diagnosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Borderline personality disorder: Epidemiology, pathogenesis, clinical features, course, assessment, and diagnosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Andrew Skodol, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Murray B Stein, MD, MPH</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michael Friedman, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jun 02, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Borderline personality disorder (BPD) is characterized by instability of interpersonal relationships, self-image, and emotions, as well as by impulsivity across a wide range of situations, causing significant impairment or subjective distress.</p><p>BPD has a lifetime prevalence of approximately 6 percent. The disorder is associated with receiving extensive clinical attention and the disorder is more widely studied than any other personality disorder. Despite these efforts, patients with BPD continue to suffer considerable morbidity and increased mortality compared with the general population [<a href="#rid1">1,2</a>].</p><p>The epidemiology, pathogenesis, clinical features, course, assessment, and diagnosis of BPD are reviewed here. The treatment and prognosis of BPD are discussed separately. Other personality disorders are also discussed separately.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/6618.html" rel="external">"Borderline personality disorder: Psychotherapy"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/6617.html" rel="external">"Overview of personality disorders"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/14760.html" rel="external">"Antisocial personality disorder: Epidemiology, clinical manifestations, course, and diagnosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/14766.html" rel="external">"Narcissistic personality disorder: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/14771.html" rel="external">"Schizotypal personality disorder: Epidemiology, pathogenesis, clinical manifestations, course, and diagnosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/108262.html" rel="external">"Borderline personality disorder: Treatment overview"</a>.)</p><p></p><p class="headingAnchor" id="H2"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Borderline personality disorder (BPD) is common in both the general population and in clinical settings. Large, nationally representative, nonclinical surveys of the United States general population estimate that the point prevalence of BPD is 1.6 percent and the lifetime prevalence is 5.9 percent [<a href="#rid3">3,4</a>]. Studies in clinical settings found BPD was present in 6.4 percent of urban primary care patients, 9.3 percent of psychiatric outpatients, and approximately 20 percent of psychiatric inpatients [<a href="#rid5">5-7</a>].</p><p>The ratio of females to males with the disorder is greater in clinical populations than it is in the general population. The ratio is 3:1 in clinical settings [<a href="#rid8">8</a>]. Two epidemiologic surveys of the United States general population, however, have found the lifetime prevalence of BPD does not differ significantly between males and females [<a href="#rid3">3,4</a>]. This discrepancy suggests that females with BPD are more likely to seek treatment than males. In a study of patients with BPD, males and females were found to have similar rates of childhood-trauma history and levels of current psychosocial functioning [<a href="#rid9">9</a>].</p><p>Study findings are mixed regarding the relationship between BPD and ethnicity. A study of patients presenting to clinical facilities found significantly higher rates of BPD in Hispanics compared with Caucasians and African Americans (64 versus 39 versus 40 percent) [<a href="#rid10">10</a>]. One United States epidemiologic study found the prevalence of BPD to be less frequent among Hispanic males and females [<a href="#rid4">4</a>], while another found that it was not significantly related to race and ethnicity [<a href="#rid3">3</a>].</p><p class="headingAnchor" id="H462912444"><span class="h2">Comorbidities</span><span class="headingEndMark"> — </span>Co-occurring psychiatric disorders are common in patients with BPD, especially mood (depressive, bipolar), anxiety, substance-use, eating, and somatoform disorders  (<a class="graphic graphic_table graphicRef52837" href="/d/graphic/52837.html" rel="external">table 1</a>) [<a href="#rid11">11-13</a>]. An epidemiologic survey found that 85 percent of individuals with BPD have at least one comorbid mental disorder [<a href="#rid3">3</a>]. The mean number of current comorbid disorders was 3.2 in the epidemiologic survey and 3.4 in a study of borderline outpatients [<a href="#rid3">3,13</a>]. Acute exacerbations of the comorbid mental disorders, sometimes accompanied by suicidal thoughts or attempts, often precipitate treatment seeking or hospitalization. (See <a class="local">'Nonsuicidal self-injury'</a> below.)</p><p>Patients with BPD frequently meet criteria for other personality disorders; however, studies have not been consistent regarding which personality disorders most frequently co-occur [<a href="#rid3">3,14</a>].</p><p>Females and males with BPD have been found to have similar rates of comorbid major depression, but differing rates of other co-occurring psychiatric disorders [<a href="#rid9">9</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Posttraumatic stress disorder (females versus males, 51 versus 31 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Eating disorder (42 versus 19 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Identity disturbance (67 versus 48 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Substance use disorder (58 versus 85 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Antisocial personality disorder (10 versus 30 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Narcissistic personality disorder (5 versus 22 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Schizotypal personality disorder (10 versus 25 percent)</p><p></p><p>Data from the National Epidemiologic Survey on Alcohol and Related Conditions III [<a href="#rid15">15,16</a>] indicated significant associations between 12-month and lifetime alcohol use disorder across all levels of alcohol use disorder severity and 12-month drug use disorder and BPD.</p><p class="headingAnchor" id="H4"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>The cause of borderline personality disorder (BPD) is not known. Most hypotheses suggest that BPD is due to a combination of genetic, neurobiologic, and psychosocial factors [<a href="#rid17">17</a>].</p><p class="headingAnchor" id="H6"><span class="h2">Genetic</span><span class="headingEndMark"> — </span>There is at least moderate evidence for the genetic transmission and heritability of BPD. Two studies found the concordance rate for BPD was higher in monozygotic twins compared with dizygotic twins (35 and 36 percent versus 7 and 19 percent) [<a href="#rid18">18,19</a>]. A third twin study found the proportion of variance in BPD in the general community explained by environmental influences was greater than that explained by genetic influences (58 versus 42 percent of the variance) [<a href="#rid20">20</a>].</p><p>In over 2000 Norwegian twins, most of the genetic influence on individual BPD criteria derived from one highly heritable general BPD factor, while environmental influences were mostly criterion specific [<a href="#rid21">21</a>]. BPD criteria counts were moderately stable over 10 years from early to middle adulthood, decreasing 28 percent, mostly due to genetic risk factors that did not change over the follow-up period [<a href="#rid22">22</a>].</p><p>Pathologic personality trait domains included in the alternative American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) model for personality disorders (see  <a class="medical medical_review" href="/d/html/107558.html" rel="external">"Dimensional-categorical approach to assessing personality disorder pathology"</a>) were found to tap the same genetic risk factors as DSM-5-TR diagnoses for BPD and most other personality disorders [<a href="#rid23">23</a>]; however, five factor model normative personality traits had considerable genetic variance not shared by DSM-5-TR personality disorders [<a href="#rid24">24</a>]. Thus, from a genetic perspective, BPD may be better represented by pathologic than normative personality traits [<a href="#rid25">25</a>].</p><p>Single candidate gene association studies of BPD, for example of genes involved in the serotonin system involved in emotional regulation, have been disappointing, with small effect sizes, nonreplication, and no significant associations after meta-analyses of studies [<a href="#rid26">26</a>].</p><p>Another approach to studying the disorder's genetic basis has tried to identify the heritability of endophenotypes, such as certain psychopathologic traits or behaviors, which may map more closely onto neurobiologic pathways. There have been only two genome-wide association studies of BPD, one of which focused on the BPD symptom domains of affect instability, identity problems, negative relationships, and self-harm in a total of 8426 patients [<a href="#rid27">27</a>]. Genetic variance was substantially higher for the affective instability domain compared to the other three domains. Seven single nucleotide polymorphisms (of 6.6 million analyzed) showed significant association – all located on chromosome 5 serine incorporator 5 gene – which facilitates myelination in cells of the nervous system. Findings based on endophenotypes may not be specific for BPD because most are transdiagnostic (ie, cut across disorder categories) and have relevance for different types of mental disorders [<a href="#rid28">28</a>].</p><p>The first and only genome-wide association study of BPD patients involved 998 BPD patients (a small sample compared with the 10,000s in genome-wide association studies of schizophrenia) and 1545 controls [<a href="#rid29">29</a>]. Single marker analysis revealed no significant associations after correcting for multiple testing. Gene-based analyses yielded two significant genes and gene set analysis yielded a significant finding for exocytosis. All identified genes have been implicated in prior studies of bipolar disorder and schizophrenia. The most notable finding of the study was the genetic overlap of BPD with bipolar disorder, schizophrenia, and major depressive disorder, again raising the issue of heterogeneity within BPD and the relevance of transdiagnostic features.</p><p>Most theories about the etiology of BPD posit that the disorder results from a combination of a genetic predisposition and adverse environmental factors such a trauma [<a href="#rid28">28</a>]. There are very few studies, however, examining gene-environment interactions in BPD patients, and these are limited by small sample sizes and failure to replicate [<a href="#rid30">30</a>]. As an example, the largest study exploring gene x environment interactions and gene x environment correlations involved 5083 twin pairs and 1285 non-twin siblings in the general population and focused on the BPD-related features of affect instability, identity problems, negative relationships, and self-harm [<a href="#rid31">31</a>]. Having experienced a traumatic life event was related to the severity of BPD traits. A gene x environment correlation was found for certain life events, meaning that the genes that put an individual at risk for developing BPD features also increase the likelihood of being exposed to some types of life events.</p><p>Future research on the genetics of BPD will likely focus increasingly on endophenotypes and on gene x environment interactions and correlations [<a href="#rid32">32</a>].</p><p class="headingAnchor" id="H7"><span class="h2">Neurobiologic</span><span class="headingEndMark"> — </span>Preclinical research suggests that perhaps altered neuropeptide function underlies the interpersonal problems of these patients [<a href="#rid33">33</a>]. Attachment insecurity, leading to impairments in social cognition, including maladaptive representations of self, others, and self in relation to others, are believed to be at the core of the interpersonal difficulties of patients with BPD [<a href="#rid34">34</a>] and may be modulated by the oxytocinergic system [<a href="#rid35">35</a>]. In addition, numerous neurotransmitter and neuroimaging studies have compared patients with BPD to healthy controls and found abnormalities such as serotonin dysfunction and bilateral reductions in the hippocampus, amygdala, and other regions of the medial temporal lobe [<a href="#rid36">36,37</a>]. It is difficult to interpret such results because the studies enrolled and investigated adult patients who already met criteria for BPD. Thus, it is not clear whether the observed neurobiologic correlates represent etiologic causes or sequelae of the disorder. Making this distinction requires a longitudinal study that enrolls premorbid children or adolescents. The specificity of the neurotransmitter and neuroimaging findings to BPD is also unknown.</p><p>Research findings demonstrate widespread neuropsychologic deficits in patient with BPD linked largely to frontal lobe functioning, and support the idea that many symptoms of the disorder, such as affective instability and identity disturbance, are due to disrupted connections between the prefrontal cortex and other brain regions controlling higher cognitive functions [<a href="#rid38">38</a>].</p><p class="headingAnchor" id="H1303151"><span class="h2">Psychosocial</span><span class="headingEndMark"> — </span>A history of childhood trauma is common in patients with BPD [<a href="#rid39">39,40</a>]. However, the relationship between trauma and BPD is not clear. Childhood trauma is not always present in patients with BPD, and many individuals who suffer abuse do not develop BPD.</p><p>The trauma that is often present in the history of patients with BPD can take many forms, including sexual abuse, physical abuse, verbal abuse, neglect, and early parental separation or loss. A systematic review found high rates of childhood sexual (16 to 71 percent) and physical (10 to 73 percent) abuse [<a href="#rid39">39,41</a>].</p><p>Clinical trials on the relationship between childhood trauma and BPD have been mixed:</p><p class="bulletIndent1"><span class="glyph">●</span>A prospective, community-based, longitudinal study of 639 children found that childhood abuse or neglect was eventually and significantly associated with BPD in young adulthood, after controlling for parental education and parental psychopathology (odds ratio 7.7, 95% CI 1.8-33.5) [<a href="#rid42">42</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A prospective study of 500 individuals with documented cases of childhood physical and sexual abuse and neglect found that more physically abused and/or neglected children met criteria for BPD as adults, compared with controls. Individuals with a history of childhood sexual abuse were not at increased risk for BPD. Having a parent with drug or alcohol problems, not being employed full-time, not being a high school graduate, and having a diagnosis of a drug use disorder, major depressive disorder, and posttraumatic stress disorder mediated the relationship between abuse and neglect and adult BPD, suggesting multiple pathways to BPD [<a href="#rid43">43</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Other studies have not found childhood sexual abuse to be a major risk factor or causal antecedent of BPD. Meta-analyses have found only small effect sizes for the association between childhood sexual abuse and BPD, as well as for the association between childhood sexual abuse and self-injurious behavior (a common manifestation of BPD) [<a href="#rid44">44,45</a>]. A meta-analysis found that college students with a history of childhood sexual abuse were only slightly less well-adjusted than control students [<a href="#rid46">46</a>]. Poorer adjustment could not be attributed to childhood sexual abuse because family environment was consistently confounded with childhood sexual abuse. A longitudinal study of over 1300 twin pairs followed from age 11 to 24 showed that the association between childhood abuse and BPD stemmed from common genetic influences, which were inherited vulnerabilities to internalizing and externalizing disorders in general [<a href="#rid47">47</a>].</p><p></p><p class="headingAnchor" id="H3162113745"><span class="h1">CLINICAL MANIFESTATIONS</span></p><p class="headingAnchor" id="H822704511"><span class="h2">Core features</span><span class="headingEndMark"> — </span>The core features of borderline personality disorder (BPD) are instability of interpersonal relationships, self-image, affect, and marked impulsivity.</p><p>A useful model organizes features of the disorder into three dimensions [<a href="#rid48">48</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Impaired relatedness – Unstable relationships with others, identity disturbance, and chronic emptiness</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Affective dysregulation – Affective lability, excessive anger, and efforts to avoid abandonment</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Behavior dysregulation – Impulsivity, suicidality, and self-injurious behavior</p><p></p><p>Affective instability was shown to be the most sensitive and specific single manifestation of BPD (and thus a potentially useful screen) in a sample of 3674 psychiatric outpatients evaluated with a semi-structured interview [<a href="#rid49">49</a>]. All manifestations of BPD are associated with psychosocial impairment in this same population, even in the absence of the others. However, only chronic emptiness was found to be a marker of all types of morbidity, including suicidality, history of suicide attempts and hospitalizations, social and work dysfunction, axis I (symptom) disorder comorbidity, and global functioning [<a href="#rid50">50</a>].</p><p class="headingAnchor" id="H1673679202"><span class="h2">Signs and behaviors</span></p><p class="headingAnchor" id="H3995192242"><span class="h3">Suicidality</span><span class="headingEndMark"> — </span>Suicidal threats, gestures, and attempts are common manifestations of BPD [<a href="#rid8">8</a>]. Approximately 8 to 12 percent of individuals with BPD have been found to commit suicide in retrospective studies [<a href="#rid51">51,52</a>]. However, data from a prospective longitudinal study of patients with BPD found a rate of suicide of 4 percent over a 10-year period [<a href="#rid53">53</a>]. A comparison of 2384 individuals who committed suicide matched to 46,899 living controls from the United Kingdom Clinical Practice Research Datalink, a primary care database, found a 37-fold increased risk of suicide among patients with BPD compared with patients with no psychiatric disorders [<a href="#rid54">54</a>].</p><p>Assessing the current risk of a patient's suicidal intent is difficult. Years of suicide threats and self-injurious behavior may precede a completed suicide [<a href="#rid55">55</a>]. The literature has identified numerous risk factors for suicidality, but none of these are consistent across studies. In a longitudinal study [<a href="#rid56">56</a>] and in an epidemiological cross-sectional study [<a href="#rid57">57</a>], chronic feelings of emptiness, identity disturbance, frantic efforts to avoid abandonment, and self-injurious behaviors were the diagnostic criteria for BPD that were independently associated with suicide attempts, with chronic feelings of emptiness found in both studies. Other factors suggesting a chronic risk include impulsivity, negative affectivity, and poor psychosocial functioning. Factors suggesting an acute risk include recent depression, adverse life events, substance misuse, and recent loss [<a href="#rid14">14</a>].</p><p>All suicidal ideation and threats should be taken seriously. The general principles of managing suicidality in patients with BPD are discussed elsewhere. Assessment, risk factors, evaluation, and management of suicidal ideation and behavior in a more generalized population are discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/108262.html" rel="external">"Borderline personality disorder: Treatment overview"</a> and  <a class="medical medical_review" href="/d/html/1708.html" rel="external">"Suicidal ideation and behavior in adults"</a>.)</p><p class="headingAnchor" id="H9"><span class="h3">Interpersonal difficulties</span><span class="headingEndMark"> — </span>Patients with BPD usually have stormy relationships, especially with people to whom patients are close [<a href="#rid58">58</a>]. At one moment, a friend or romantic partner may be viewed not only as a trusted confidant but as an ideal, almost perfect person, and then this same individual can suddenly be seen as cruel, betraying, very limited, and damaged. When the idealized person is present and supportive, the patient feels strong and solid. However, if the support person leaves (or is unable to meet the patient's needs), even for a limited time, or if the patient thinks that the support person is about to leave, the patient can immediately become angry, demeaning, demanding, depressed, hopeless, and suicidal.</p><p>Patients tend to view others as all good or all bad, a phenomenon that has been labeled "splitting" [<a href="#rid59">59</a>]. Rigidly classifying other people as good or bad can lead the patient to shift between extreme points of view and to selectively attend to information in a way that confirms their current opinion. This tendency to "split" can impact treatment. (See  <a class="medical medical_review" href="/d/html/6618.html" rel="external">"Borderline personality disorder: Psychotherapy"</a>.)</p><p>Patients with BPD often interpret neutral events, words, or faces as "negative" [<a href="#rid60">60,61</a>]. Thus, the patient is prone to misinterpret relatively minor disagreements or adverse events as a sign that the caretaker wants to terminate the relationship. The patient often reacts with anger or threats of self-harm, which can alienate the support person, who then may really want to end the relationship. This heightened sensitivity to actual or perceived rejection most likely is what leads to patients often feeling more comfortable or secure with a “transitional object,” such as a pet or stuffed animal, than with other people.</p><p class="headingAnchor" id="H10"><span class="h3">Affective instability</span><span class="headingEndMark"> — </span>Patients can experience repeated and marked mood changes throughout the course of a single day, with moment to moment fluctuations often triggered by environmental stressors. Periods of euthymia can alternate with intense, episodic dysphoria that includes depression, anxiety, and irritability. Angry outbursts triggered by dissatisfaction with a caregiver are often followed by feelings of shame, guilt, and worthlessness.</p><p class="headingAnchor" id="H11"><span class="h3">Impulsivity</span><span class="headingEndMark"> — </span>Impetuous and self-damaging behavior is common and can take many forms. Patients abuse substances, binge eat, engage in unsafe sex, spend money irresponsibly, and drive recklessly. In addition, patients can suddenly quit a job that they need or end a relationship that has the potential to last, thereby sabotaging their own success. Impulsivity can also manifest with immature and regressive behavior and often takes the form of sexually acting out. (See <a class="local">'Nonsuicidal self-injury'</a> below.)</p><p>As in nonsuicidal self-injury (NSSI), impulsivity in the sexual realm can have important utility or meaning to the patient (eg, helping to relieve inner tension or feeling loved following a recent real or perceived interpersonal rejection). Although the patient may be regretful of their behavior afterwards and may even appreciate its potential dangerousness, they may find it very difficult, if not impossible to resist the urge to repeat the behavior.</p><p class="headingAnchor" id="H12"><span class="h3">Cognition</span><span class="headingEndMark"> — </span>Neuropsychologic functioning in patients with BPD is impaired in many domains. A meta-analysis comparing patients with healthy controls found that cognitive functioning in patients was substantially and significantly poorer on tests of [<a href="#rid38">38</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Attention</p><p class="bulletIndent1"><span class="glyph">●</span>Cognitive flexibility</p><p class="bulletIndent1"><span class="glyph">●</span>Learning and memory</p><p class="bulletIndent1"><span class="glyph">●</span>Planning</p><p class="bulletIndent1"><span class="glyph">●</span>Processing speed</p><p class="bulletIndent1"><span class="glyph">●</span>Visuospatial abilities</p><p></p><p class="headingAnchor" id="H14"><span class="h3">Nonsuicidal self-injury</span><span class="headingEndMark"> — </span>Patients may engage in self-injurious behavior that is not intended as suicide, such as cutting or burning themselves [<a href="#rid62">62</a>]. The patient can usually acknowledge the behavior as a compulsive act that relieves tension, often described as “inner tension,” and lacks suicidal intent. Nevertheless, self-injurious behavior should be evaluated to determine whether it involves suicidal intent.</p><p>Patients may feel that the relief of tension provided by NSSI prevents them from progressing to suicidal ideation, gestures, or acts. Patients who are told that their therapist will stop seeing them if they continue to self-injure may panic and become more suicidal, particularly if the patient is strongly attached to the therapist. This is not to suggest that the therapist should condone NSSI but rather its meaning to the patient should be explored and influence how action is taken.</p><p class="headingAnchor" id="H462913066"><span class="h1">COURSE</span><span class="headingEndMark"> — </span>Limited epidemiologic [<a href="#rid63">63</a>] and clinical [<a href="#rid64">64</a>] data suggest that the onset of borderline personality disorder (BPD) occurs in adolescence or early adulthood. Diagnosis in adolescents has shown similar stability, reliability, and validity to diagnosis in adults [<a href="#rid65">65</a>]. In contrast to longstanding beliefs that BPD had a chronic, unchanging course over the lifespan, a review of 13 follow-up studies that evaluated BPD patients using semistructured interviews and explicit diagnostic criteria found that remission occurred in 45 percent of patients with BPD over a wide range of follow-up periods [<a href="#rid66">66</a>]. In the last two decades, more rigorous longitudinal prospective studies also found that most patients experience remission of the disorder [<a href="#rid67">67-70</a>].</p><p>As examples:</p><p class="bulletIndent1"><span class="glyph">●</span>In a prospective study of 290 patients with BPD interviewed every two years for up to 16 years found the following rates of remission (defined as no longer meeting BPD diagnostic criteria for at least two years) [<a href="#rid68">68-70</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>35 percent after 2 years</p><p class="bulletIndent2"><span class="glyph">•</span>91 percent after 10 years</p><p class="bulletIndent2"><span class="glyph">•</span>99 percent after 16 years</p><p></p><p class="bulletIndent1">The duration of remission was prolonged for many patients [<a href="#rid70">70</a>]. Seventy-eight percent achieved a remission that lasted for at least eight years. Factors associated with a shorter time to remission [<a href="#rid68">68</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Age 25 or younger (odds ratio 1.46)</p><p class="bulletIndent2"><span class="glyph">•</span>Good functioning at work or school in the two years prior to study (odds ratio 1.61)</p><p class="bulletIndent2"><span class="glyph">•</span>No history of childhood sexual abuse (odds ratio 1.43)</p><p class="bulletIndent2"><span class="glyph">•</span>No family history of substance abuse (odds ratio 1.40)</p><p class="bulletIndent2"><span class="glyph">•</span>Absence of comorbid anxious cluster Axis II disorder (odds ratio 1.49)</p><p class="bulletIndent2"><span class="glyph">•</span>Low neuroticism (odds ratio 0.97)</p><p class="bulletIndent2"><span class="glyph">•</span>High agreeableness and affiliating tendencies (odds ratio 1.04)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a study of 175 patients followed for 10 years that employed somewhat stricter definitions of symptomatic remission, 91 percent of patients with BPD had a period of two months or more with only two or fewer criteria of BPD manifest, and 85 percent had a period of 12 months or more with two or fewer criteria [<a href="#rid71">71</a>].</p><p></p><p>Psychosocial functioning improved more slowly than other BPD symptoms in these studies [<a href="#rid71">71,72</a>]. Improvement on the Global Assessment of Functioning Scale, while statistically significant, remained small – an average of 4 points on the 100-point scale over 10 years [<a href="#rid71">71</a>]. The proportion of patients achieving good psychosocial functioning increased steadily over study periods ranging from 6 to 15 years [<a href="#rid14">14,73</a>].</p><p>Recurrence was common in patients who remitted and attained good levels of functioning. In the longitudinal study of 290 BPD patients, 34 percent of the patients who remitted, later experienced symptoms and functional impairment once again meeting BPD diagnostic criteria [<a href="#rid70">70</a>].</p><p>High rates of remission and recurrence in prospective studies have challenged the traditional conceptualization of BPD as a stable and enduring pattern of maladaptive traits. One reconceptualization that has been proposed is BPD as a hybrid of stable personality traits and intermittently expressed symptomatic behaviors [<a href="#rid74">74</a>]. In the 16-year follow-up of patients with BPD, acute symptoms such as self-mutilation were more likely to remit over two years and for a period of four years than were temperamental symptoms (traits) such as chronic anger [<a href="#rid75">75</a>]. Another view is that BPD may be better classified as a mental state or what was called in the past an axis I disorder [<a href="#rid76">76</a>], although this belies the observation that there is little difference between the stability/instability of most mental disorders.</p><p class="headingAnchor" id="H30627707"><span class="h1">ASSESSMENT</span><span class="headingEndMark"> — </span>The clinical diagnosis of borderline personality disorder (BPD) should be based on a comprehensive psychiatric assessment. Clinicians should use all available sources of information to make the diagnosis, including the patient's self-reported clinical history, the clinician's observations during interviews, and information from family, friends, and medical records when available and legitimately accessible.</p><p>Patients should be carefully evaluated for co-occurring mental disorders and substance use disorders, along with suicidality and other self-injurious behavior. (See  <a class="medical medical_review" href="/d/html/1708.html" rel="external">"Suicidal ideation and behavior in adults"</a>.)</p><p class="headingAnchor" id="H30627753"><span class="h2">Instruments for diagnosis and severity rating</span><span class="headingEndMark"> — </span>A self-report measure called the McLean Screening Instrument for Borderline Personality Disorder is available to screen patients for the disorder [<a href="#rid77">77</a>]. Each of the 10 items is dichotomous, and the instrument has good psychometric properties (sensitivity 0.81 and specificity 0.85). This tool is intended only for screening and not for rendering a final diagnosis.</p><p>Several validated personality disorder assessment instruments are available to diagnose any of the personality disorders, including BPD. These instruments systematically assess each criterion for every personality disorder. Self-report instruments such as the Personality Diagnostic Questionnaire [<a href="#rid78">78</a>] have the advantage of saving interviewer time, but often yield false positive diagnoses.</p><p>Some interview instruments are designed specifically for the assessment of BPD, such as the Revised Diagnostic Interview for Borderlines [<a href="#rid28">28</a>]. The Structured Clinical Interview for the DSM-5 Alternative Model for Personality Disorders [<a href="#rid79">79</a>] is a new interview for the assessment of the dimensional and categorical components of the alternative model for personality disorder, including BPD. (See  <a class="medical medical_review" href="/d/html/107558.html" rel="external">"Dimensional-categorical approach to assessing personality disorder pathology"</a>.)</p><p class="headingAnchor" id="H16"><span class="h1">DIAGNOSIS</span></p><p class="headingAnchor" id="H3143754430"><span class="h2">DSM-5-TR criteria</span><span class="headingEndMark"> — </span>The DSM-5-TR diagnostic criteria for borderline personality disorder (BPD) are found on a table  (<a class="graphic graphic_table graphicRef63127" href="/d/graphic/63127.html" rel="external">table 2</a>) [<a href="#rid80">80</a>]:</p><p>All nine of the DSM-5-TR diagnostic criteria are common in patients with BPD. The frequency of each diagnostic criterion in a group of 201 patients with BPD was [<a href="#rid81">81</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Affective instability (95 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Inappropriate anger (87 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Impulsivity (81 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Unstable relationships (79 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Feelings of emptiness (71 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Paranoia or dissociation (68 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Identity disturbance (61 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Abandonment fears (60 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Suicidality or self-injury (60 percent)</p><p></p><p>BPD can be overdiagnosed, with indiscriminate or pejorative application of the term to angry, irritating, demanding, difficult, or self-destructive patients [<a href="#rid82">82</a>]. In many clinicians’ minds, angry, irritating behavior becomes equivalent to the diagnosis of BPD. Yet many other diagnostic entities and conditions can lead to these types of behaviors, such as bipolar disorder manic, chronic substance misuse, chronic pain, chronic marital or work related stress, and chronic paranoid states. The clinician needs to see beyond their reaction to annoying aspects of a patient’s behavior to collect and evaluate the data needed to make an accurate diagnosis.</p><p>BPD can also be underdiagnosed; the stigma that continues to be attached to the diagnosis makes some clinicians reluctant to apply it to a patient, a perspective that may impact their attitudes during a patient’s treatment [<a href="#rid83">83,84</a>].</p><p>Making the diagnosis of BPD can be difficult in the presence of co-occurring psychiatric disorders, especially when confounded by countertransference reactions. Symptoms of other disorders, such as an episodic mood disorder, can overlap with and overshadow the more stable psychopathology of BPD. A study found, however, that personality disorders diagnosed during a major depressive episode were as valid as those diagnosed in the absence of depression, indicating that it is possible to tease out significant personality psychopathology when a patient is depressed [<a href="#rid85">85</a>]. (See <a class="local">'Comorbidities'</a> above.)</p><p class="headingAnchor" id="H3073459336"><span class="h2">Discussing the diagnosis</span><span class="headingEndMark"> — </span>To have a frank and open discussion about treatment options with a patient, most clinicians agree that the diagnosis should be discussed with them [<a href="#rid86">86</a>]. This subject is discussed separately. (See  <a class="medical medical_review" href="/d/html/6617.html" rel="external">"Overview of personality disorders", section on 'Discussing the diagnosis'</a>.)</p><p>A patient with BPD needs to know that BPD is a recognized psychiatric disorder with both genetic (biologic) and psychosocial underpinnings. The diagnosis does not render the patient’s prognosis hopeless – there are effective forms of treatment, especially in the psychotherapeutic realm, and remission is relatively common. (See <a class="local">'Course'</a> above.)</p><p class="headingAnchor" id="H308101042"><span class="h2">Adolescents</span><span class="headingEndMark"> — </span>Although traits of BPD may appear as early as childhood, the diagnosis is generally not given to children or young adolescents. Traits of the disorder that appear in childhood may be specific to a particular developmental stage and change as the individual reaches adulthood. Some adolescents meeting criteria for the disorder will “mature out” of the symptoms and behaviors without treatment.</p><p>We are not currently able to predict which children will experience persistence of the disorder into adulthood. However, older adolescents with highly severe and pervasive manifestations of the disorder may be most likely to benefit from diagnosis accompanied by early intervention. Some studies suggest that youth with more manifestations of personality disorders in adolescence may be at greater risk for the disorders as adults (ie, there may be a rank-order stability of manifestations, even if there is the possibility of “maturing out”) [<a href="#rid87">87,88</a>]. Additionally, symptoms of BPD in early adolescence are associated with increased risk of interpersonal difficulties, poor mental health (eg, increased suicidal and self-harming behavior), poor functional outcomes (eg, no training or job opportunities), and higher likelihood of being a victim of violence by age 18 [<a href="#rid89">89</a>].</p><p class="headingAnchor" id="H308101050"><span class="h2">ICD-10</span><span class="headingEndMark"> — </span>The World Health Organization International Classification of Diseases, 10<sup>th</sup> revision (ICD-10) uses the term "emotionally unstable personality disorder, borderline type" to classify these patients  (<a class="graphic graphic_table graphicRef57216" href="/d/graphic/57216.html" rel="external">table 3</a>) [<a href="#rid90">90</a>].</p><p class="headingAnchor" id="H17"><span class="h2">Diagnostic instruments</span><span class="headingEndMark"> — </span>Interviewer-administered instruments such as the Structured Clinical Interview for DSM-5 Personality Disorders [<a href="#rid91">91</a>] enable the interviewer to clarify contradictory or ambiguous patient responses, but are labor intensive and generally reserved for specialized evaluation, treatment, or research settings.</p><p>There are also validated instruments specifically designed for diagnosing only BPD. Examples are the self-report Borderline Symptom List [<a href="#rid92">92</a>], the Minnesota Borderline Personality Disorder Scale [<a href="#rid93">93</a>], and the Personality Assessment Inventory Borderline Features Scale [<a href="#rid94">94-96</a>]. A trait-based assessment can be done with the NEO Five-Factor Inventory-BPD [<a href="#rid97">97</a>].</p><p>Inter-rater and test-retest reliabilities among different semistructured interviews used to diagnose BPD are good to excellent (kappa = 0.68 to 0.96 for inter-rater and kappa = 0.40 to 0.85 for test-retest) [<a href="#rid98">98</a>]. Reliability is mostly a function of interviewer training and experience.</p><p class="headingAnchor" id="H18"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>In addition to the comorbidity that can occur in the presence of borderline personality disorder (BPD), described above, BPD needs to be discriminated from other psychiatric disorders as part of a systematic differential diagnosis. These disorders include both symptom disorders and other personality disorders, in particular (see <a class="local">'Comorbidities'</a> above and <a class="local">'Diagnosis'</a> above):</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bipolar disorder</strong> – The alternating mood syndromes ("mood swings") of bipolar I, bipolar II, or cyclothymic disorder can resemble the affective instability of BPD. The distinguishing feature is that the depressive or mood elevated syndromes in bipolar disorder are longer in duration compared with the labile affective states of BPD. (See <a class="local">'Affective instability'</a> above.)</p><p></p><p class="bulletIndent1">Mood syndromes in bipolar disorder are less connected to events in the environment, compared with the affective instability of BPD that is often triggered by stressors such as perceived rejection or failure. (See  <a class="medical medical_review" href="/d/html/14642.html" rel="external">"Bipolar disorder in adults: Clinical features", section on 'Clinical presentation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Major depressive disorder</strong> – The dysphoria that characterizes major depressive disorder is present most of the day, nearly every day, for at least two weeks, whereas BPD is marked by affective states that fluctuate within a single day. (See <a class="local">'Affective instability'</a> above.)</p><p></p><p class="bulletIndent1">Major depressive disorder also involves sustained neurovegetative symptoms related to sleep, appetite, and energy, which are not features of BPD. In addition, BPD is marked by symptoms such as identity disturbance and frantic efforts to avoid abandonment, which are not part of major depressive disorder or other mental disorders. (See  <a class="medical medical_review" href="/d/html/1721.html" rel="external">"Unipolar depression in adults: Assessment and diagnosis", section on 'Unipolar major depression'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Persistent depressive disorder</strong> – Chronic dysphoria, overeating, and low self-esteem are symptoms of persistent depressive disorder (formerly dysthymia), and can also occur in BPD. Persistent depressive disorder involves sustained symptoms related to sleep and energy, which are not part of BPD. (See  <a class="medical medical_review" href="/d/html/1721.html" rel="external">"Unipolar depression in adults: Assessment and diagnosis", section on 'Persistent depressive disorder (dysthymia)'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Posttraumatic stress disorder</strong> – A history of trauma, which is central to the diagnosis of posttraumatic stress disorder, is often seen in patients with BPD. Posttraumatic stress disorder is characterized by symptoms of reexperiencing the traumatic event, avoidance and numbing, and increased arousal, which are not part of BPD. Problems with self-image and interpersonal relationships characteristic of BPD are not typically part of posttraumatic stress disorder in the absence of personality pathology. In addition, exacerbation of symptoms in posttraumatic stress disorder is due to specific environmental triggers, whereas symptoms of BPD are exacerbated by more general stressors and frustrations or perceived interpersonal slights. (See  <a class="medical medical_review" href="/d/html/500.html" rel="external">"Posttraumatic stress disorder in adults: Epidemiology, pathophysiology, clinical features, assessment, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dissociative identity disorder</strong> – Disturbance of identity is common to both BPD and dissociative identity disorder. The distinguishing feature is that dissociative identity disorder is characterized by two or more distinct identities or personality states, each with its own enduring pattern of behavior, whereas the identity disturbance in BPD consists of an unstable and fluctuating sense of self, with sudden changes in self-image, goals, and values. (See  <a class="medical medical_review" href="/d/html/14700.html" rel="external">"Dissociative identity disorder: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Attention deficit hyperactivity disorder (ADHD) </strong>– Impulsivity may characterize both ADHD and BPD. Affective lability is also a frequently associated feature of ADHD. BPD is not typically characterized by inattention and ADHD is not characterized by fears of abandonment, a tendency toward self-injury, or interpersonal relationships characterized by alterations between extremes of idealization and devaluation.</p><p></p><p>BPD shares certain features with other personality disorders [<a href="#rid7">7</a>]. The greatest amount of overlap occurs with the other cluster B (dramatic, emotional, erratic) personality disorders.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Antisocial personality disorder</strong> – The manipulative behavior characteristic of antisocial personality disorder is directed at gaining power or material gratification, whereas patients with BPD are manipulative for the purpose of gaining the concern of caretakers. Patients with antisocial personality disorder are also more emotionally stable and aggressive compared with patients with BPD. (See  <a class="medical medical_review" href="/d/html/14760.html" rel="external">"Antisocial personality disorder: Epidemiology, clinical manifestations, course, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Histrionic personality disorder</strong> – Affective instability as well as manipulative and attention-seeking behavior can occur in both histrionic personality disorder and BPD. The two disorders can be distinguished by symptoms that occur only in BPD, such as self-destructive behavior, frequent angry disruptions in relationships, and chronic feelings of emptiness. (See  <a class="medical medical_review" href="/d/html/6617.html" rel="external">"Overview of personality disorders", section on 'Histrionic'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Narcissistic personality disorder</strong> – Angry reactions to relatively minor provocations characterize both narcissistic personality disorder and BPD. In narcissistic personality disorder, this behavior occurs in the context of a stable, grandiose self-image and without the self-destructive behavior, impulsivity, and fear of abandonment that mark BPD. (See  <a class="medical medical_review" href="/d/html/14766.html" rel="external">"Narcissistic personality disorder: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Paranoid personality disorder</strong> – Suspiciousness or paranoia, as well as angry reactions to minor stimuli, can occur in both paranoid personality disorder and BPD. Paranoid personality disorder is distinguished by a more pervasive suspiciousness and stable self-image, and lacks the self-destructive behavior, impulsivity, and fear of abandonment that characterize BPD. (See  <a class="medical medical_review" href="/d/html/6617.html" rel="external">"Overview of personality disorders", section on 'Paranoid'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Schizotypal personality disorder</strong> – Both schizotypal personality disorder and BPD share psychotic-like symptoms and difficulty with relationships. Patients with schizotypal personality disorder are more emotionally stable and less impulsive, and their difficulty with relationships stems from odd thinking and strange behavior. In BPD, the psychotic-like episodes are more transient, and the difficulty with relationships is due to affective instability and angry outbursts resulting from abandonment fears and impairments in social cognition. (See  <a class="medical medical_review" href="/d/html/14771.html" rel="external">"Schizotypal personality disorder: Epidemiology, pathogenesis, clinical manifestations, course, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dependent personality disorder</strong> – The excessive need to be taken care of and fear of abandonment seen in dependent personality disorder leads to increasing appeasement and submissiveness when relationships are threatened, whereas the patient with BPD reacts with rage and feelings of emptiness. In addition, interpersonal relationships of people with dependent personality disorder are more stable than those of people with BPD. (See  <a class="medical medical_review" href="/d/html/6617.html" rel="external">"Overview of personality disorders", section on 'Dependent'</a>.)</p><p></p><p class="headingAnchor" id="H462168311"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/122640.html" rel="external">"Society guideline links: Personality disorders"</a>.)</p><p class="headingAnchor" id="H21279068"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, “The Basics” and “Beyond the Basics.” The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on “patient info” and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/d/html/16579.html" rel="external">"Patient education: Borderline personality disorder (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H21"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology </strong>– Borderline personality disorder (BPD) is a common illness. The point prevalence in the United States general population is estimated to be 1.6 percent with a lifetime prevalence of approximately 6 percent. Prevalence rates in the general population to be comparable between females and males; however, the prevalence of BPD in clinical samples is higher in females compared with males. (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1">Co-occurring psychiatric disorders such as mood disorders, anxiety disorders, substance use, eating, and somatoform disorders are common in BPD. (See <a class="local">'Comorbidities'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Core features</strong> – The core features of BPD are instability of interpersonal relationships, self-image, and affect, as well as marked impulsivity. Other signs and behaviors include (see <a class="local">'Clinical manifestations'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Suicidality – We closely monitor individuals with suicidality in the form of threats, gestures, attempts, and nonsuicidal self-injury closely. We take all threats of self-harm seriously and do a full assessment of suicide risk. Predicting suicide is very difficult. (See <a class="local">'Suicidality'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Interpersonal difficulty – (See <a class="local">'Interpersonal difficulties'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Affective instability – (See <a class="local">'Affective instability'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Impulsivity – (See <a class="local">'Impulsivity'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Neuropsychological impairment – (See <a class="local">'Cognition'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Nonsuicidal self-injury – (See <a class="local">'Nonsuicidal self-injury'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Course </strong>– The onset of BPD occurs in adolescence or early adulthood. Diagnosis in adolescents has shown stability, reliability, and validity similar to that of diagnosis in adults.</p><p></p><p class="bulletIndent1">High rates of remission and recurrence have challenged the traditional conceptualization of BPD as a stable and enduring pattern of maladaptive traits. One reconceptualization that has been proposed is BPD as a hybrid of stable personality traits and intermittently expressed symptomatic behaviors. (See <a class="local">'Course'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Assessment </strong>– We diagnose BPD based on comprehensive psychiatric assessment. We obtain information from family, friends, prior treatment and medical records when available. Validated personality disorder assessment instruments (eg, McLean Screening Instrument for Borderline Personality Disorder) may be useful as screening tools.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> – The diagnosis of BPD is based on the American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) criteria. Diagnosis may be complicated by the presence of co-occurring mood, anxiety, and/or substance use disorders, which are seen at higher rates in patients with BPD. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Children and adolescents</strong> – Children or young adolescents are generally not diagnosed with BPD. Traits of the disorder that may appear in childhood can change as these patients reach adulthood. Adolescents with highly severe and pervasive manifestations of the disorder may be most likely to benefit from diagnosis accompanied by early intervention. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Differential diagnosis </strong>– BPD needs to be discriminated from other psychiatric disorders as part of a systematic differential diagnosis. These include: bipolar disorder, depressive disorders, posttraumatic stress disorder, dissociative identity disorder, attention deficit hyperactivity disorder, as well as other personality disorders.</p><p></p><p class="headingAnchor" id="H3250367789"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Kenneth R Silk, MD (deceased), who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Blashfield RK, Intoccia V. Growth of the literature on the topic of personality disorders. Am J Psychiatry 2000; 157:472.</a></li><li><a class="nounderline abstract_t">Bender DS, Dolan RT, Skodol AE, et al. Treatment utilization by patients with personality disorders. Am J Psychiatry 2001; 158:295.</a></li><li><a class="nounderline abstract_t">Lenzenweger MF, Lane MC, Loranger AW, Kessler RC. DSM-IV personality disorders in the National Comorbidity Survey Replication. Biol Psychiatry 2007; 62:553.</a></li><li><a class="nounderline abstract_t">Grant BF, Chou SP, Goldstein RB, et al. Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2008; 69:533.</a></li><li><a class="nounderline abstract_t">Gross R, Olfson M, Gameroff M, et al. Borderline personality disorder in primary care. Arch Intern Med 2002; 162:53.</a></li><li><a class="nounderline abstract_t">Zimmerman M, Rothschild L, Chelminski I. The prevalence of DSM-IV personality disorders in psychiatric outpatients. Am J Psychiatry 2005; 162:1911.</a></li><li class="breakAll">American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), American Psychiatric Association, 2013.</li><li class="breakAll">American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR), Fourth edition, Text revision, American Psychiatric Association, Washington, DC 2000.</li><li><a class="nounderline abstract_t">Johnson DM, Shea MT, Yen S, et al. Gender differences in borderline personality disorder: findings from the Collaborative Longitudinal Personality Disorders Study. Compr Psychiatry 2003; 44:284.</a></li><li><a class="nounderline abstract_t">Chavira DA, Grilo CM, Shea MT, et al. Ethnicity and four personality disorders. Compr Psychiatry 2003; 44:483.</a></li><li><a class="nounderline abstract_t">Shea MT, Stout RL, Yen S, et al. Associations in the course of personality disorders and Axis I disorders over time. J Abnorm Psychol 2004; 113:499.</a></li><li><a class="nounderline abstract_t">Zanarini MC, Frankenburg FR, Dubo ED, et al. Axis I comorbidity of borderline personality disorder. Am J Psychiatry 1998; 155:1733.</a></li><li><a class="nounderline abstract_t">Zimmerman M, Mattia JI. Axis I diagnostic comorbidity and borderline personality disorder. Compr Psychiatry 1999; 40:245.</a></li><li><a class="nounderline abstract_t">American Psychiatric Association Practice Guidelines. Practice guideline for the treatment of patients with borderline personality disorder. American Psychiatric Association. Am J Psychiatry 2001; 158:1.</a></li><li><a class="nounderline abstract_t">Grant BF, Goldstein RB, Saha TD, et al. Epidemiology of DSM-5 alcohol use disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions III. JAMA Psychiatry 2015; 72:757.</a></li><li><a class="nounderline abstract_t">Grant BF, Saha TD, Ruan WJ, et al. Epidemiology of DSM-5 drug use disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III. JAMA Psychiatry 2016; 73:39.</a></li><li><a class="nounderline abstract_t">Caspi A, McClay J, Moffitt TE, et al. Role of genotype in the cycle of violence in maltreated children. Science 2002; 297:851.</a></li><li><a class="nounderline abstract_t">Torgersen S, Lygren S, Oien PA, et al. A twin study of personality disorders. Compr Psychiatry 2000; 41:416.</a></li><li><a class="nounderline abstract_t">Kendler KS, Aggen SH, Czajkowski N, et al. The structure of genetic and environmental risk factors for DSM-IV personality disorders: a multivariate twin study. Arch Gen Psychiatry 2008; 65:1438.</a></li><li><a class="nounderline abstract_t">Distel MA, Trull TJ, Derom CA, et al. Heritability of borderline personality disorder features is similar across three countries. Psychol Med 2008; 38:1219.</a></li><li><a class="nounderline abstract_t">Reichborn-Kjennerud T, Ystrom E, Neale MC, et al. Structure of genetic and environmental risk factors for symptoms of DSM-IV borderline personality disorder. JAMA Psychiatry 2013; 70:1206.</a></li><li><a class="nounderline abstract_t">Reichborn-Kjennerud T, Czajkowski N, Ystrøm E, et al. A longitudinal twin study of borderline and antisocial personality disorder traits in early to middle adulthood. Psychol Med 2015; 45:3121.</a></li><li><a class="nounderline abstract_t">Reichborn-Kjennerud T, Krueger RF, Ystrom E, et al. Do DSM-5 Section II personality disorders and Section III personality trait domains reflect the same genetic and environmental risk factors? Psychol Med 2017; 47:2205.</a></li><li><a class="nounderline abstract_t">Czajkowski N, Aggen SH, Krueger RF, et al. A Twin Study of Normative Personality and DSM-IV Personality Disorder Criterion Counts: Evidence for Separate Genetic Influences. Am J Psychiatry 2018; 175:649.</a></li><li><a class="nounderline abstract_t">Skodol AE. Can Personality Disorders Be Redefined in Personality Trait Terms? Am J Psychiatry 2018; 175:590.</a></li><li><a class="nounderline abstract_t">Bassir Nia A, Eveleth MC, Gabbay JM, et al. Past, present, and future of genetic research in borderline personality disorder. Curr Opin Psychol 2018; 21:60.</a></li><li><a class="nounderline abstract_t">Lubke GH, Laurin C, Amin N, et al. Genome-wide analyses of borderline personality features. Mol Psychiatry 2014; 19:923.</a></li><li><a class="nounderline abstract_t">Gunderson JG, Herpertz SC, Skodol AE, et al. Borderline personality disorder. Nat Rev Dis Primers 2018; 4:18029.</a></li><li><a class="nounderline abstract_t">Witt SH, Streit F, Jungkunz M, et al. Genome-wide association study of borderline personality disorder reveals genetic overlap with bipolar disorder, major depression and schizophrenia. Transl Psychiatry 2017; 7:e1155.</a></li><li><a class="nounderline abstract_t">Carpenter RW, Tomko RL, Trull TJ, Boomsma DI. Gene-environment studies and borderline personality disorder: a review. Curr Psychiatry Rep 2013; 15:336.</a></li><li><a class="nounderline abstract_t">Distel MA, Middeldorp CM, Trull TJ, et al. Life events and borderline personality features: the influence of gene-environment interaction and gene-environment correlation. Psychol Med 2011; 41:849.</a></li><li><a class="nounderline abstract_t">Ruocco AC, Carcone D. A neurobiological model of borderline personality disorder: Systematic and integrative review. Harv Rev Psychiatry 2016; 24:311.</a></li><li><a class="nounderline abstract_t">Stanley B, Siever LJ. The interpersonal dimension of borderline personality disorder: toward a neuropeptide model. Am J Psychiatry 2010; 167:24.</a></li><li><a class="nounderline abstract_t">Beeney JE, Stepp SD, Hallquist MN, et al. Attachment and social cognition in borderline personality disorder: Specificity in relation to antisocial and avoidant personality disorders. Personal Disord 2015; 6:207.</a></li><li><a class="nounderline abstract_t">Herpertz SC, Bertsch K. A new perspective on the pathophysiology of borderline personality disorder: A model of the role of oxytocin. Am J Psychiatry 2015; 172:840.</a></li><li><a class="nounderline abstract_t">Hansenne M, Pitchot W, Pinto E, et al. 5-HT1A dysfunction in borderline personality disorder. Psychol Med 2002; 32:935.</a></li><li><a class="nounderline abstract_t">Soloff P, Nutche J, Goradia D, Diwadkar V. Structural brain abnormalities in borderline personality disorder: a voxel-based morphometry study. Psychiatry Res 2008; 164:223.</a></li><li><a class="nounderline abstract_t">Ruocco AC. The neuropsychology of borderline personality disorder: a meta-analysis and review. Psychiatry Res 2005; 137:191.</a></li><li><a class="nounderline abstract_t">Zanarini MC. Childhood experiences associated with the development of borderline personality disorder. Psychiatr Clin North Am 2000; 23:89.</a></li><li><a class="nounderline abstract_t">Geselowitz B, Whalen DJ, Tillman R, et al. Preschool Age Predictors of Adolescent Borderline Personality Symptoms. J Am Acad Child Adolesc Psychiatry 2021; 60:612.</a></li><li><a class="nounderline abstract_t">Zanarini MC, Williams AA, Lewis RE, et al. Reported pathological childhood experiences associated with the development of borderline personality disorder. Am J Psychiatry 1997; 154:1101.</a></li><li><a class="nounderline abstract_t">Johnson JG, Cohen P, Brown J, et al. Childhood maltreatment increases risk for personality disorders during early adulthood. Arch Gen Psychiatry 1999; 56:600.</a></li><li><a class="nounderline abstract_t">Widom CS, Czaja SJ, Paris J. A prospective investigation of borderline personality disorder in abused and neglected children followed up into adulthood. J Pers Disord 2009; 23:433.</a></li><li><a class="nounderline abstract_t">Fossati A, Madeddu F, Maffei C. Borderline Personality Disorder and childhood sexual abuse: a meta-analytic study. J Pers Disord 1999; 13:268.</a></li><li><a class="nounderline abstract_t">Klonsky ED, Moyer A. Childhood sexual abuse and non-suicidal self-injury: meta-analysis. Br J Psychiatry 2008; 192:166.</a></li><li><a class="nounderline abstract_t">Rind B, Tromovitch P, Bauserman R. A meta-analytic examination of assumed properties of child sexual abuse using college samples. Psychol Bull 1998; 124:22.</a></li><li><a class="nounderline abstract_t">Bornovalova MA, Huibregtse BM, Hicks BM, et al. Tests of a direct effect of childhood abuse on adult borderline personality disorder traits: a longitudinal discordant twin design. J Abnorm Psychol 2013; 122:180.</a></li><li><a class="nounderline abstract_t">Sanislow CA, Grilo CM, McGlashan TH. Factor analysis of the DSM-III-R borderline personality disorder criteria in psychiatric inpatients. Am J Psychiatry 2000; 157:1629.</a></li><li><a class="nounderline abstract_t">Zimmerman M, Multach MD, Dalrymple K, Chelminski I. Clinically useful screen for borderline personality disorder in psychiatric out-patients. Br J Psychiatry 2017; 210:165.</a></li><li><a class="nounderline abstract_t">Ellison WD, Rosenstein L, Chelminski I, et al. The clinical significance of single features of borderline personality disorder: Anger, affective instability, impulsivity, and chronic emptiness in psychiatric outpatients. J Pers Disord 2016; 30:261.</a></li><li><a class="nounderline abstract_t">Pompili M, Girardi P, Ruberto A, Tatarelli R. Suicide in borderline personality disorder: a meta-analysis. Nord J Psychiatry 2005; 59:319.</a></li><li><a class="nounderline abstract_t">Paris J. Implications of long-term outcome research for the management of patients with borderline personality disorder. Harv Rev Psychiatry 2002; 10:315.</a></li><li><a class="nounderline abstract_t">Zanarini MC, Frankenburg FR, Hennen J, et al. The McLean Study of Adult Development (MSAD): overview and implications of the first six years of prospective follow-up. J Pers Disord 2005; 19:505.</a></li><li><a class="nounderline abstract_t">Doyle M, While D, Mok PL, et al. Suicide risk in primary care patients diagnosed with a personality disorder: a nested case control study. BMC Fam Pract 2016; 17:106.</a></li><li><a class="nounderline abstract_t">Soloff PH, Fabio A. Prospective predictors of suicide attempts in borderline personality disorder at one, two, and two-to-five year follow-up. J Pers Disord 2008; 22:123.</a></li><li><a class="nounderline abstract_t">Yen S, Peters JR, Nishar S, et al. Association of Borderline Personality Disorder Criteria With Suicide Attempts: Findings From the Collaborative Longitudinal Study of Personality Disorders Over 10 Years of Follow-up. JAMA Psychiatry 2021; 78:187.</a></li><li><a class="nounderline abstract_t">Grilo CM, Udo T. Association of Borderline Personality Disorder Criteria With Suicide Attempts Among US Adults. JAMA Netw Open 2021; 4:e219389.</a></li><li><a class="nounderline abstract_t">Lieb K, Zanarini MC, Schmahl C, et al. Borderline personality disorder. Lancet 2004; 364:453.</a></li><li class="breakAll">Gunderson JG, Links PG. Borderline Personality Disorder, A Clinical Guide, American Psychiatric Press, 2008.</li><li><a class="nounderline abstract_t">Korfine L, Hooley JM. Directed forgetting of emotional stimuli in borderline personality disorder. J Abnorm Psychol 2000; 109:214.</a></li><li><a class="nounderline abstract_t">Donegan NH, Sanislow CA, Blumberg HP, et al. Amygdala hyperreactivity in borderline personality disorder: implications for emotional dysregulation. Biol Psychiatry 2003; 54:1284.</a></li><li><a class="nounderline abstract_t">Zanarini MC, Laudate CS, Frankenburg FR, et al. Reasons for self-mutilation reported by borderline patients over 16 years of prospective follow-up. J Pers Disord 2013; 27:783.</a></li><li><a class="nounderline abstract_t">Johnson JG, Cohen P, Kasen S, et al. Cumulative prevalence of personality disorders between adolescence and adulthood. Acta Psychiatr Scand 2008; 118:410.</a></li><li><a class="nounderline abstract_t">Chanen AM, Jackson HJ, McGorry PD, et al. Two-year stability of personality disorder in older adolescent outpatients. J Pers Disord 2004; 18:526.</a></li><li><a class="nounderline abstract_t">Kaess M, Brunner R, Chanen A. Borderline personality disorder in adolescence. Pediatrics 2014; 134:782.</a></li><li><a class="nounderline abstract_t">Skodol AE, Siever LJ, Livesley WJ, et al. The borderline diagnosis II: biology, genetics, and clinical course. Biol Psychiatry 2002; 51:951.</a></li><li><a class="nounderline abstract_t">Skodol AE, Bender DS, Pagano ME, et al. Positive childhood experiences: resilience and recovery from personality disorder in early adulthood. J Clin Psychiatry 2007; 68:1102.</a></li><li><a class="nounderline abstract_t">Zanarini MC, Frankenburg FR, Hennen J, et al. Prediction of the 10-year course of borderline personality disorder. Am J Psychiatry 2006; 163:827.</a></li><li><a class="nounderline abstract_t">Zanarini MC, Frankenburg FR, Reich DB, Fitzmaurice G. Time to attainment of recovery from borderline personality disorder and stability of recovery: A 10-year prospective follow-up study. Am J Psychiatry 2010; 167:663.</a></li><li><a class="nounderline abstract_t">Zanarini MC, Frankenburg FR, Reich DB, Fitzmaurice G. Attainment and stability of sustained symptomatic remission and recovery among patients with borderline personality disorder and axis II comparison subjects: a 16-year prospective follow-up study. Am J Psychiatry 2012; 169:476.</a></li><li><a class="nounderline abstract_t">Gunderson JG, Stout RL, McGlashan TH, et al. Ten-year course of borderline personality disorder: psychopathology and function from the Collaborative Longitudinal Personality Disorders study. Arch Gen Psychiatry 2011; 68:827.</a></li><li><a class="nounderline abstract_t">Skodol AE, Pagano ME, Bender DS, et al. Stability of functional impairment in patients with schizotypal, borderline, avoidant, or obsessive-compulsive personality disorder over two years. Psychol Med 2005; 35:443.</a></li><li><a class="nounderline abstract_t">Zanarini MC, Frankenburg FR, Hennen J, et al. Psychosocial functioning of borderline patients and axis II comparison subjects followed prospectively for six years. J Pers Disord 2005; 19:19.</a></li><li><a class="nounderline abstract_t">Skodol AE, Gunderson JG, Shea MT, et al. The Collaborative Longitudinal Personality Disorders Study (CLPS): overview and implications. J Pers Disord 2005; 19:487.</a></li><li><a class="nounderline abstract_t">Zanarini MC, Frankenburg FR, Reich DB, Fitzmaurice GM. Fluidity of the Subsyndromal Phenomenology of Borderline Personality Disorder Over 16 Years of Prospective Follow-Up. Am J Psychiatry 2016; 173:688.</a></li><li><a class="nounderline abstract_t">Tyler P. Why borderline personality disorder is neither borderline nor a personality disorder. Personal Ment Health 2009; 3:86.</a></li><li><a class="nounderline abstract_t">Zanarini MC, Vujanovic AA, Parachini EA, et al. A screening measure for BPD: the McLean Screening Instrument for Borderline Personality Disorder (MSI-BPD). J Pers Disord 2003; 17:568.</a></li><li><a class="nounderline abstract_t">Hyler SE, Skodol AE, Kellman HD, et al. Validity of the Personality Diagnostic Questionnaire--revised: comparison with two structured interviews. Am J Psychiatry 1990; 147:1043.</a></li><li class="breakAll">First MB, Skodol AE, Bender DS, Oldham JM. User’s Guide for the Structured Clinical Interview for the DSM-5 Alternative Model for Personality Disorders (SCID-5-AMPD), American Psychiatric Association Publishing, Arlington 2018.</li><li class="breakAll">American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR), Washington, DC 2022.</li><li><a class="nounderline abstract_t">McGlashan TH, Grilo CM, Sanislow CA, et al. Two-year prevalence and stability of individual DSM-IV criteria for schizotypal, borderline, avoidant, and obsessive-compulsive personality disorders: toward a hybrid model of axis II disorders. Am J Psychiatry 2005; 162:883.</a></li><li class="breakAll">First MB, Frances A, Pincus HA. DSM-IV Guidebook, American Psychiatric Press, Inc., 2004.</li><li><a class="nounderline abstract_t">Aviram RB, Brodsky BS, Stanley B. Borderline personality disorder, stigma, and treatment implications. Harv Rev Psychiatry 2006; 14:249.</a></li><li><a class="nounderline abstract_t">Hersh R. Confronting myths and stereotypes about borderline personality disorder. Soc Work Ment Health 2008; 6:13.</a></li><li><a class="nounderline abstract_t">Morey LC, Shea MT, Markowitz JC, et al. State effects of major depression on the assessment of personality and personality disorder. Am J Psychiatry 2010; 167:528.</a></li><li><a class="nounderline abstract_t">Lequesne ER, Hersh RG. Disclosure of a diagnosis of borderline personality disorder. J Psychiatr Pract 2004; 10:170.</a></li><li><a class="nounderline abstract_t">Johnson JG, Cohen P, Kasen S, et al. Age-related change in personality disorder trait levels between early adolescence and adulthood: a community-based longitudinal investigation. Acta Psychiatr Scand 2000; 102:265.</a></li><li><a class="nounderline abstract_t">de Clercq B, van Leeuwen K, van den Noortgate W, et al. Childhood personality pathology: dimensional stability and change. Dev Psychopathol 2009; 21:853.</a></li><li><a class="nounderline abstract_t">Wertz J, Caspi A, Ambler A, et al. Borderline Symptoms at Age 12 Signal Risk for Poor Outcomes During the Transition to Adulthood: Findings From a Genetically Sensitive Longitudinal Cohort Study. J Am Acad Child Adolesc Psychiatry 2020; 59:1165.</a></li><li class="breakAll">World Health Organization. International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Version for 2007.</li><li class="breakAll">First MB, Gibbon M, Spitzer RL, et al. Structured Clinical Interview for DSM-IV Axis II Personality Disorders, (SCID-II), American Psychiatric Press, Inc., 1997.</li><li><a class="nounderline abstract_t">Bohus M, Kleindienst N, Limberger MF, et al. The short version of the Borderline Symptom List (BSL-23): development and initial data on psychometric properties. Psychopathology 2009; 42:32.</a></li><li><a class="nounderline abstract_t">Rojas EC, Hicks BM, Stark S, et al. Elaborating on the construct validity of the Minnesota Borderline Personality Disorder Scale (MBPD): a multi-sample, longitudinal examination. Psychol Assess 2015; 27:332.</a></li><li><a class="nounderline abstract_t">Stein MB, Pinsker-Aspen JH, Hilsenroth MJ. Borderline pathology and the Personality Assessment Inventory (PAI): an evaluation of criterion and concurrent validity. J Pers Assess 2007; 88:81.</a></li><li><a class="nounderline abstract_t">De Moor MH, Distel MA, Trull TJ, Boomsma DI. Assessment of borderline personality features in population samples: is the Personality Assessment Inventory-Borderline Features scale measurement invariant across sex and age? Psychol Assess 2009; 21:125.</a></li><li><a class="nounderline abstract_t">Morey LC. Borderline features are associated with inaccurate trait self-estimations. Borderline Personal Disord Emot Dysregul 2014; 1:4.</a></li><li><a class="nounderline abstract_t">Few LR, Miller JD, Grant JD, et al. Trait-based assessment of borderline personality disorder using the NEO Five-Factor Inventory: Phenotypic and genetic support. Psychol Assess 2016; 28:39.</a></li><li class="breakAll">National Institute for Health and Clinical Excellence. Borderline Personality Disorder: Treatment and Management. 2009. Available at: http://www.nice.org.uk/CG78 (Accessed on February 12, 2010).</li></ol></div><div id="topicVersionRevision">Topic 6619 Version 32.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10698831" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Growth of the literature on the topic of personality disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11156814" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Treatment utilization by patients with personality disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17217923" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : DSM-IV personality disorders in the National Comorbidity Survey Replication.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18426259" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11784220" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Borderline personality disorder in primary care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16199838" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : The prevalence of DSM-IV personality disorders in psychiatric outpatients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16199838" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : The prevalence of DSM-IV personality disorders in psychiatric outpatients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16199838" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : The prevalence of DSM-IV personality disorders in psychiatric outpatients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12923706" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Gender differences in borderline personality disorder: findings from the Collaborative Longitudinal Personality Disorders Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14610727" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Ethnicity and four personality disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15535783" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Associations in the course of personality disorders and Axis I disorders over time.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9842784" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Axis I comorbidity of borderline personality disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10428182" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Axis I diagnostic comorbidity and borderline personality disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11665545" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Practice guideline for the treatment of patients with borderline personality disorder. American Psychiatric Association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26039070" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Epidemiology of DSM-5 alcohol use disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions III.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26580136" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Epidemiology of DSM-5 drug use disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12161658" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Role of genotype in the cycle of violence in maltreated children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11086146" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : A twin study of personality disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19047531" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : The structure of genetic and environmental risk factors for DSM-IV personality disorders: a multivariate twin study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17988414" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Heritability of borderline personality disorder features is similar across three countries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24048243" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Structure of genetic and environmental risk factors for symptoms of DSM-IV borderline personality disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26050739" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : A longitudinal twin study of borderline and antisocial personality disorder traits in early to middle adulthood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28414014" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Do DSM-5 Section II personality disorders and Section III personality trait domains reflect the same genetic and environmental risk factors?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29558815" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : A Twin Study of Normative Personality and DSM-IV Personality Disorder Criterion Counts: Evidence for Separate Genetic Influences.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29961368" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Can Personality Disorders Be Redefined in Personality Trait Terms?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29032046" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Past, present, and future of genetic research in borderline personality disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23979607" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Genome-wide analyses of borderline personality features.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29795363" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Borderline personality disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28632202" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Genome-wide association study of borderline personality disorder reveals genetic overlap with bipolar disorder, major depression and schizophrenia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23250817" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Gene-environment studies and borderline personality disorder: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20594379" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Life events and borderline personality features: the influence of gene-environment interaction and gene-environment correlation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27603741" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : A neurobiological model of borderline personality disorder: Systematic and integrative review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19952075" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : The interpersonal dimension of borderline personality disorder: toward a neuropeptide model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25705979" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Attachment and social cognition in borderline personality disorder: Specificity in relation to antisocial and avoidant personality disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26324303" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : A new perspective on the pathophysiology of borderline personality disorder: A model of the role of oxytocin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12171388" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : 5-HT1A dysfunction in borderline personality disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19019636" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Structural brain abnormalities in borderline personality disorder: a voxel-based morphometry study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16297985" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : The neuropsychology of borderline personality disorder: a meta-analysis and review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10729933" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Childhood experiences associated with the development of borderline personality disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32950651" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Preschool Age Predictors of Adolescent Borderline Personality Symptoms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9247396" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Reported pathological childhood experiences associated with the development of borderline personality disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10401504" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Childhood maltreatment increases risk for personality disorders during early adulthood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19817626" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : A prospective investigation of borderline personality disorder in abused and neglected children followed up into adulthood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10498039" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Borderline Personality Disorder and childhood sexual abuse: a meta-analytic study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18310572" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Childhood sexual abuse and non-suicidal self-injury: meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9670820" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : A meta-analytic examination of assumed properties of child sexual abuse using college samples.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22686871" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Tests of a direct effect of childhood abuse on adult borderline personality disorder traits: a longitudinal discordant twin design.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11007717" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Factor analysis of the DSM-III-R borderline personality disorder criteria in psychiatric inpatients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27908898" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Clinically useful screen for borderline personality disorder in psychiatric out-patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25893552" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : The clinical significance of single features of borderline personality disorder: Anger, affective instability, impulsivity, and chronic emptiness in psychiatric outpatients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16757458" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Suicide in borderline personality disorder: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12485978" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Implications of long-term outcome research for the management of patients with borderline personality disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16274279" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : The McLean Study of Adult Development (MSAD): overview and implications of the first six years of prospective follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27495284" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Suicide risk in primary care patients diagnosed with a personality disorder: a nested case control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18419233" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Prospective predictors of suicide attempts in borderline personality disorder at one, two, and two-to-five year follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33206138" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Association of Borderline Personality Disorder Criteria With Suicide Attempts: Findings From the Collaborative Longitudinal Study of Personality Disorders Over 10 Years of Follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33974054" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Association of Borderline Personality Disorder Criteria With Suicide Attempts Among US Adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15288745" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Borderline personality disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15288745" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Borderline personality disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10895559" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Directed forgetting of emotional stimuli in borderline personality disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14643096" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Amygdala hyperreactivity in borderline personality disorder: implications for emotional dysregulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23795756" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Reasons for self-mutilation reported by borderline patients over 16 years of prospective follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18644003" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Cumulative prevalence of personality disorders between adolescence and adulthood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15615665" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Two-year stability of personality disorder in older adolescent outpatients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25246626" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Borderline personality disorder in adolescence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12062878" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : The borderline diagnosis II: biology, genetics, and clinical course.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17685749" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Positive childhood experiences: resilience and recovery from personality disorder in early adulthood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16648323" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Prediction of the 10-year course of borderline personality disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20395399" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Time to attainment of recovery from borderline personality disorder and stability of recovery: A 10-year prospective follow-up study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22737693" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Attainment and stability of sustained symptomatic remission and recovery among patients with borderline personality disorder and axis II comparison subjects: a 16-year prospective follow-up study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21464343" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Ten-year course of borderline personality disorder: psychopathology and function from the Collaborative Longitudinal Personality Disorders study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15841879" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Stability of functional impairment in patients with schizotypal, borderline, avoidant, or obsessive-compulsive personality disorder over two years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15899718" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Psychosocial functioning of borderline patients and axis II comparison subjects followed prospectively for six years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16274278" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : The Collaborative Longitudinal Personality Disorders Study (CLPS): overview and implications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26869248" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Fluidity of the Subsyndromal Phenomenology of Borderline Personality Disorder Over 16 Years of Prospective Follow-Up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Why borderline personality disorder is neither borderline nor a personality disorder</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14744082" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : A screening measure for BPD: the McLean Screening Instrument for Borderline Personality Disorder (MSI-BPD).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2197883" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Validity of the Personality Diagnostic Questionnaire--revised: comparison with two structured interviews.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2197883" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Validity of the Personality Diagnostic Questionnaire--revised: comparison with two structured interviews.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2197883" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Validity of the Personality Diagnostic Questionnaire--revised: comparison with two structured interviews.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15863789" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Two-year prevalence and stability of individual DSM-IV criteria for schizotypal, borderline, avoidant, and obsessive-compulsive personality disorders: toward a hybrid model of axis II disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15863789" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Two-year prevalence and stability of individual DSM-IV criteria for schizotypal, borderline, avoidant, and obsessive-compulsive personality disorders: toward a hybrid model of axis II disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16990170" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Borderline personality disorder, stigma, and treatment implications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Confronting myths and stereotypes about borderline personality disorder</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20160004" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : State effects of major depression on the assessment of personality and personality disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15330223" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Disclosure of a diagnosis of borderline personality disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11089726" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Age-related change in personality disorder trait levels between early adolescence and adulthood: a community-based longitudinal investigation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19583887" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Childhood personality pathology: dimensional stability and change.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31325594" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Borderline Symptoms at Age 12 Signal Risk for Poor Outcomes During the Transition to Adulthood: Findings From a Genetically Sensitive Longitudinal Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31325594" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Borderline Symptoms at Age 12 Signal Risk for Poor Outcomes During the Transition to Adulthood: Findings From a Genetically Sensitive Longitudinal Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31325594" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Borderline Symptoms at Age 12 Signal Risk for Poor Outcomes During the Transition to Adulthood: Findings From a Genetically Sensitive Longitudinal Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19023232" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : The short version of the Borderline Symptom List (BSL-23): development and initial data on psychometric properties.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25558963" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Elaborating on the construct validity of the Minnesota Borderline Personality Disorder Scale (MBPD): a multi-sample, longitudinal examination.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17266418" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Borderline pathology and the Personality Assessment Inventory (PAI): an evaluation of criterion and concurrent validity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19290772" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Assessment of borderline personality features in population samples: is the Personality Assessment Inventory-Borderline Features scale measurement invariant across sex and age?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26401288" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Borderline features are associated with inaccurate trait self-estimations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25984635" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Trait-based assessment of borderline personality disorder using the NEO Five-Factor Inventory: Phenotypic and genetic support.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
